Relative Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial

MLA

Li Q, et al. “Relative Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial.” Neuropsychiatric Disease and Treatment, vol. ume 18, Aug. 2022, pp. 1653–64. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.b41fc37d433c4d90b6f88c97fbce66f4&authtype=sso&custid=ns315887.

APA

Li Q, Zhang H, Lin G, Shi S, Zhang Y, Ji J, Yang L, Yao J, & Wu W. (2022). Relative Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial. Neuropsychiatric Disease and Treatment, ume 18, 1653–1664.

Chicago

Li Q, Zhang H, Lin G, Shi S, Zhang Y, Ji J, Yang L, Yao J, and Wu W. 2022. “Relative Safety and Efficacy of Two Doses of Tandospirone Citrate for Generalized Anxiety Disorder: A Multicenter Randomized Controlled Trial.” Neuropsychiatric Disease and Treatment ume 18 (August): 1653–64. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.b41fc37d433c4d90b6f88c97fbce66f4&authtype=sso&custid=ns315887.